Insiders · Profile

Fox Christine Ann

Chief Financial Officer at Mereo BioPharma. Filing since 25 Jun 2024. CIK 0002005755

Company
Date
Role
Action
Shares
Amount
Of holding
13 Sep 2024
Chief Financial Officer
Sold at will
19,158
$80.87K
17.7%
12 Sep 2024
Chief Financial Officer
Sold at will
9,128
$40.83K
7.8%
26 Jun 2024
Chief Financial Officer
Sold at will
29,439
$99.89K
33.8%
25 Jun 2024
Chief Financial Officer
Sold at will
12,990
$47.98K
13.0%
4 decisions on file.